Rating History for Entasis Therapeutics (ETTX) by Cantor Fitzgerald
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/6/2022 | Louise Chen | Downgrade | Neutral (Overweight) |
2.00 (5.00) |
1.91 (2.19) |
14.66% | Details |
 |
|||||||
|
|||||||
